Keyphrases
Acute Myeloid Leukemia
100%
Macrophages
100%
Patient Outcomes
100%
Therapy Resistance
100%
Leukemia Patients
16%
Clinical Outcomes
16%
Bone Marrow Microenvironment
16%
Leukaemic Cells
16%
Acute Myeloid Leukemia Cells
16%
Leukemia
8%
Pathophysiology
8%
Resident Cells
8%
Disease Relapse
8%
Traditional Treatment
8%
Immune Cells
8%
Macrophage Phenotype
8%
Therapeutic Targeting
8%
Resistance Mechanisms
8%
Targeted Treatment
8%
Existing Challenges
8%
CD163
8%
Proteomics
8%
Cell Death Pathways
8%
Prognostic Value
8%
Hematological Malignancies
8%
Macrophage Reprogramming
8%
Therapy-resistant
8%
Preclinical in Vivo Models
8%
Macrophage Subsets
8%
Disease-specific Mortality
8%
CD206
8%
Resistant Mechanism
8%
Curative Treatment
8%
TP53 mutation
8%
Medicine and Dentistry
Macrophage
100%
Therapy Resistance
100%
Acute Myeloid Leukemia
100%
Bone Marrow Microenvironment
14%
Leukemia Cell
14%
Disease
7%
Leukemia
7%
Targeted Therapy
7%
Cell Death
7%
Proteomics
7%
Pathophysiology
7%
Immunocompetent Cell
7%
Macrophage Subset
7%
Hematologic Malignancy
7%
Immunology and Microbiology
Macrophage
100%
Myeloid
100%
Bone Marrow Microenvironment
14%
Leukemia Cell
14%
Cell Death
7%
Immunocompetent Cell
7%
CD163
7%
Macrophage Subset
7%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Myeloid Leukemia
100%
Therapy Resistance
100%
Pathophysiology
7%
Leukemia
7%
Combination Therapy
7%
Hematologic Malignancy
7%